AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 284: H1693-H1701, 2003. First published January 9, 2003; doi:10.1152/ajpheart.00730.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/5/H1693    most recent
00730.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farias, M.
Right arrow Articles by Caffrey, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farias, M., III
Right arrow Articles by Caffrey, J. L.
Vol. 284, Issue 5, H1693-H1701, May 2003

Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node

Martin Farias III, Keith E. Jackson, Darice Yoshishige, and James L. Caffrey

Department of Integrative Physiology, University of North Texas Health Science Center, Fort Worth, Texas 76107

Local cardiac opioids appear to be important in determining the quality of vagal control of heart rate. Introduction of the endogenous opioid methionine-enkephalin-arginine-phenylalanine (MEAP) into the interstitium of the canine sinoatrial node by microdialysis attenuates vagally mediated bradycardia through a delta -opioid receptor mechanism. The following studies were conducted to test the hypothesis that a delta 2-opiate receptor subtype mediates the interruption of vagal transmission. Twenty mongrel dogs were anesthetized and instrumented with microdialysis probes inserted into the sinoatrial node. Vagal frequency responses were performed at 1, 2, and 3 Hz during vehicle infusion and during treatment with the native agonist MEAP, the delta 1-opioids 2-methyl-4aa-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12aalpha -octahydroquinolino[2,3,3- g]isoquinoline (TAN-67) and [D-pen2,5]-enkephalin (DPDPE), and the delta 2 opioid deltorphin II. The vagolytic effects of intranodal MEAP and deltorphin were then challenged with the delta 1- and delta 2-opioid receptor antagonists 7-benzylidenenaltrexone (BNTX) and naltriben, respectively. Although the positive control deltorphin II was clearly vagolytic in each experimental group, TAN-67 and DPDPE were vagolytically ineffective in the same animals. In contrast, TAN-67 improved vagal bradycardia by 30-35%. Naltriben completely reversed the vagolytic effects of MEAP and deltorphin. BNTX was ineffective in this regard but did reverse the vagal improvement observed with TAN-67. These data support the hypothesis that the vagolytic effect of the endogenous opioid MEAP was mediated by delta 2-opioid receptors located in the sinoatrial node. These data also support the existence of vagotonic delta 1-opioid receptors also in the sinoatrial node.

TAN-67; heart rate


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey
Repeated Arterial Occlusion, Delta-Opioid Receptor (DOR) Plasticity and Vagal Transmission Within the Sinoatrial Node of the Anesthetized Dog
Experimental Biology and Medicine, January 1, 2009; 234(1): 84 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey
Cholinergic location of {delta}-opioid receptors in canine atria and SA node
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H829 - H838.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, S. Johnson-Davis, M. A. Barlow, D. Yoshishige, and J. L. Caffrey
Repeated {delta}1-opioid receptor stimulation reduces {delta}2-opioid receptor responses in the SA node
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2246 - H2254.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. A. Barlow, S. Deo, S. Johnson, and J. L. Caffrey
Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms.
Experimental Biology and Medicine, April 1, 2006; 231(4): 387 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Farias III, K. Jackson, M. Johnson, and J. L. Caffrey
Cardiac enkephalins attenuate vagal bradycardia: interactions with NOS-1-cGMP systems in canine sinoatrial node
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2001 - H2012.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. F. K. Jackson, D. Yoshishige, and J. L. Caffrey
Bimodal {delta}-opioid receptors regulate vagal bradycardia in canine sinoatrial node
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1332 - H1339.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online